MYCN and neuroblastoma: Although the role of Hh-related autophagy seems to be confused currently, encouraging results from MYCN-amplified neuroblastoma and BCR-ABL mutation CML studies underscored the possibility of co-modulating Hh signaling and autophagy to overcome drug resistance in different cancer domains.